Elite Trades From Anywhere

$100 Off Your First Year

00
Days
00
Hours
00
Mins
00
Sec
Claim Now
Last Close
0.4666
Jul 01 • 04:00PM ET Dollar change+0.0207 Percentage change(4.64%)
Index
-
Market Cap
6.73M
Enterprise Value
12.93M
Income
-33.25M
Sales
7.68M
Book/sh
0.52
Cash/sh
1.20
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
54
IPO
Sep 23, 2016
P/E
-
Forward P/E
-
PEG
-
P/S
0.88
P/B
0.90
P/C
0.39
P/FCF
-
EV/EBITDA
-
EV/Sales
1.68
Quick Ratio
3.59
Current Ratio
3.80
Debt/Eq
3.81
LT Debt/Eq
3.70
Option/Short
No / Yes
EPS (ttm)
-4.41
EPS next Y
-1.25
EPS next Q
-0.55
EPS this Y
53.12%
EPS next Y
33.51%
EPS next 5Y
45.76%
EPS past 3/5Y
52.44% 30.89%
Sales past 3/5Y
- 54.47%
EPS Y/Y TTM
71.98%
Sales Y/Y TTM
107.26%
EPS Q/Q
56.67%
Sales Q/Q
65.54%
Insider Own
2.27%
Insider Trans
0.00%
Inst Own
10.96%
Inst Trans
-0.50%
ROA
-101.61%
ROE
-337.40%
ROIC
-115.50%
Gross Margin
3.28%
Oper. Margin
-378.23%
Profit Margin
-432.99%
SMA20
11.41%
SMA50
0.72%
SMA200
-59.24%
Trades
Shs Outstand
11.79M
Shs Float
-
52W High
4.78 -90.24%
52W Low
0.33 39.49%
Volatility
13.40% 12.13%
ATR (14)
0.05
RSI (14)
53.95
Beta
0.22
Rel Volume
0.47
Avg Volume
342.21K
Volume
161,840
Perf Week
-2.59%
Perf Month
-4.03%
Perf Quarter
-32.40%
Perf Half Y
-33.78%
Perf YTD
-35.73%
Perf Year
-86.51%
Perf 3Y
-99.45%
Perf 5Y
-99.63%
Perf 10Y
-
Prev Close
0.45
Price
0.47
Change
4.64%
Date Action Analyst Rating Change Price Target Change
Jul-17-25Initiated D. Boral Capital Buy $11
Jun-25-24Downgrade BTIG Research Buy → Neutral
Jul-28-23Initiated Piper Sandler Overweight $10
Jun-15-23Initiated BTIG Research Buy $15
Apr-28-21Initiated Truist Buy $12
Oct-22-19Initiated Oppenheimer Outperform $9
Jun-26-26 03:00PM
07:00AM
Jun-22-26 04:01PM
Jun-10-26 08:00AM
Jun-01-26 08:00AM
08:00AM Loading…
Apr-20-26 08:00AM
Apr-15-26 08:00AM
Apr-01-26 09:00AM
Mar-26-26 04:05PM
Mar-17-26 04:35PM
Mar-11-26 07:00AM
Mar-10-26 07:30AM
Mar-04-26 05:39AM
Feb-20-26 08:00PM
08:00AM
04:32PM Loading…
Feb-13-26 04:32PM
07:30AM
Feb-04-26 08:00AM
Jan-27-26 04:05PM
Jan-26-26 04:05PM
Jan-14-26 08:30AM
Jan-13-26 01:40PM
07:30AM
Dec-30-25 07:30AM
Dec-17-25 07:30AM
Nov-26-25 04:30PM
Nov-11-25 12:02AM
Nov-10-25 04:05PM
Nov-05-25 08:00AM
Oct-23-25 08:00AM
08:00AM Loading…
Sep-22-25 08:00AM
Sep-08-25 03:55PM
08:00AM
Sep-03-25 08:00AM
Aug-20-25 08:00AM
Aug-13-25 03:11AM
Aug-12-25 05:35PM
04:05PM
Aug-11-25 09:45AM
Aug-07-25 06:20PM
Jul-25-25 08:00AM
Jul-22-25 07:30AM
Jun-26-25 09:55AM
Jun-18-25 03:01AM
Jun-17-25 05:15PM
04:01PM
Jun-16-25 09:16AM
08:00AM
May-29-25 08:15AM
May-28-25 05:20PM
May-20-25 08:00AM
Apr-24-25 04:05PM
Apr-21-25 04:05PM
Apr-15-25 04:05PM
Apr-09-25 04:05PM
Apr-01-25 08:00AM
Mar-31-25 08:00AM
Mar-24-25 04:05PM
Mar-23-25 08:38AM
Mar-11-25 07:30AM
Mar-06-25 04:05PM
Feb-10-25 04:05PM
Feb-07-25 07:10AM
Feb-05-25 09:29AM
Jan-27-25 04:05PM
Jan-24-25 09:15AM
Jan-06-25 08:00AM
Dec-03-24 04:05PM
Dec-02-24 07:30AM
Nov-26-24 07:30AM
Nov-14-24 04:05PM
Nov-11-24 04:05PM
07:00AM
Nov-08-24 07:06AM
Oct-29-24 04:22PM
Oct-07-24 07:00AM
Oct-02-24 07:30AM
Sep-28-24 07:40AM
07:35AM
Sep-27-24 07:34AM
07:32AM
07:30AM
Sep-23-24 08:00AM
Aug-06-24 04:05PM
Jul-31-24 04:15PM
Jul-23-24 04:05PM
Jul-16-24 04:05PM
Jul-10-24 09:55AM
Jun-26-24 08:01AM
Jun-25-24 10:31AM
08:28AM
07:37AM
Jun-24-24 08:53PM
05:25PM
04:15PM
Jun-13-24 04:05PM
Jun-03-24 07:00AM
May-23-24 04:09PM
May-01-24 07:00AM
Mar-21-24 12:00PM
Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. It operates through the Beyond Air, Beyond Cancer segments, and NeuroNos. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.
Chief Operating OfficerMr. Michael A. Gaul
Chief Executive Officer of NeuroNOSMr. Amir Avniel
CEO & DirectorMr. Robert Scott Goodman
Chief Financial OfficerMr. Daniel J. Moorhead CPA
Principal Accounting Officer & ControllerMr. Denton Drewell
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lisi Steven A.CEO and Chairman of the BoardJul 21 '25Buy3.256,00019,4913,327,411Jul 23 04:05 PM